(Q61979084)
Statements
An Open-Label, Three-Part, Two Period, Single Sequence Study to Assess the Pharmacokinetic Interaction Between Repeat Doses of Oral Casopitant and Repeat Oral Doses of Dolasetron, Granisetron or Rosiglitazone When Co-Administered in Healthy Adult Subjects (English)
0 references
23 July 2007
0 references
21 September 2007
0 references
16
0 references
18 year
0 references
64 year
0 references